Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Hui Sun, Chunlin Jin, Huishan Wang, Shanlian Hu, Yingyao Chen & Haiyin Wang. (2022) Cost-effectiveness of stereotactic body radiotherapy in the treatment of non–small-cell lung cancer (NSCLC): a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 22:5, pages 723-734.
Read now
Read now
Olfred Hansen, Charlotte Kristiansen, Morten Nielsen, Tine Schytte & Stefan Starup Jeppesen. (2019) Survival after stereotactic radiotherapy in patients with early-stage non-small cell lung cancer. Acta Oncologica 58:10, pages 1399-1403.
Read now
Read now
Qianqian Zhao, Gang Chen, Luxi Ye, Zhaochong Zeng, Shiming Shi & Jian He. (2018) Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer. Cancer Management and Research 10, pages 6391-6398.
Read now
Read now
Donata von Reibnitz, Fauzia Shaikh, Abraham J. Wu, Gregory C. Treharne, Rosalind Dick-Godfrey, Amanda Foster, Kaitlin M. Woo, Weiji Shi, Zhigang Zhang, Shaun U. Din, Daphna Y. Gelblum, Ellen D. Yorke, Kenneth E. Rosenzweig & Andreas Rimner. (2018) Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). Acta Oncologica 57:11, pages 1567-1573.
Read now
Read now
S. S. Jeppesen, N. C. G. Hansen, T. Schytte & O. Hansen. (2018) Survival of localized NSCLC patients without active treatment or treated with SBRT. Acta Oncologica 57:2, pages 219-225.
Read now
Read now
Cai Grau, Morten Høyer, Per Rugaard Poulsen, Ludvig Paul Muren, Stine Sofia Korreman, Kari Tanderup, Jacob Christian Lindegaard, Jan Alsner & Jens Overgaard. (2017) Rethink radiotherapy – BIGART 2017. Acta Oncologica 56:11, pages 1341-1352.
Read now
Read now
Charlotte Kristiansen, Tine Schytte, Karin Holmskov Hansen, Eva Holtved & Olfred Hansen. (2016) Trends in lung cancer in elderly in Denmark, 1980–2012. Acta Oncologica 55:sup1, pages 46-51.
Read now
Read now
Derek P. Bergsma, Joseph K Salama, Deepinder P. Singh, Steven J Chmura & Michael T. Milano. (2015) The evolving role of radiotherapy in treatment of oligometastatic NSCLC. Expert Review of Anticancer Therapy 15:12, pages 1459-1471.
Read now
Read now
Cai Grau, Jens Overgaard, Morten Høyer, Kari Tanderup, Jacob Christian Lindegaard & Ludvig Paul Muren. (2015) Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncologica 54:9, pages 1245-1250.
Read now
Read now
Marie Tvilum, Azza A. Khalil, Ditte S. Møller, Lone Hoffmann & Marianne M. Knap. (2015) Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients. Acta Oncologica 54:9, pages 1430-1437.
Read now
Read now
Olfred Hansen, Tine Schytte, Morten Nielsen & Carsten Brink. (2015) Age dependent prognosis in concurrent chemo-radiation of locally advanced NSCLC. Acta Oncologica 54:3, pages 333-339.
Read now
Read now
Tine Schytte, Tine Bjørn Nielsen, Carsten Brink & Olfred Hansen. (2014) Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer. Acta Oncologica 53:3, pages 336-341.
Read now
Read now
Articles from other publishers (42)
Aliss Tsz Ching Chang, Calvin S.H. Ng & Nariman Nezami. (2024) Treatment strategies for malignant pulmonary nodule: beyond lobectomy. Point-counterpoint. Current Opinion in Pulmonary Medicine 30:1, pages 35-47.
Crossref
Crossref
Yanhong Shi, Xiaoyan Ma, Dan He, Bingwei Dong & Tianyun Qiao. (2023) Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy. Frontiers in Immunology 14.
Crossref
Crossref
Hui Sun, Huishan Wang, Yan Wei, Haiyin Wang, Chunlin Jin & Yingyao Chen. (2023) Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Crossref
Kristian Kirkelund Bentsen, Johanne Andersen Hojbjerg, Pernille Just Vinholt, Olfred Hansen, Anne-Mette Hvas & Stefan Starup Jeppesen. (2023) Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer. Clinical and Applied Thrombosis/Hemostasis 29.
Crossref
Crossref
Stefania Volpe, Gaia Piperno, Francesca Colombo, Annalisa Biffi, Stefania Comi, Federico Mastroleo, Anna Maria Camarda, Alessia Casbarra, Federica Cattani, Giulia Corrao, Filippo de Marinis, Lorenzo Spaggiari, Matthias Guckenberger, Roberto Orecchia, Daniela Alterio & Barbara Alicja Jereczek-Fossa. (2022) Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis. Cancer Treatment Reviews 110, pages 102464.
Crossref
Crossref
A Pryczynicz, Adrian Romańczyk, A Ustymowicz & JAN PAWLUCZUK. (2022) Basaloid squamous cell carcinoma of the rectum. Case report. Progress in Health Sciences 12:1, pages 121-124.
Crossref
Crossref
Corbin D. Jacobs, Kurren Mehta, Junheng Gao, Xiaofei Wang, Joseph K. Salama, Chris R. Kelsey & Jordan A. Torok. (2022) Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. Clinical Lung Cancer 23:2, pages 177-184.
Crossref
Crossref
Hamed Nosrati, Farzad Seidi, Ali Hosseinmirzaei, Navid Mousazadeh, Ali Mohammadi, Mohammadreza Ghaffarlou, Hossein Danafar, João Conde & Ali Sharafi. (2021) Prodrug Polymeric Nanoconjugates Encapsulating Gold Nanoparticles for Enhanced X‐Ray Radiation Therapy in Breast Cancer. Advanced Healthcare Materials 11:3, pages 2102321.
Crossref
Crossref
P Kinkopf, A Modiri, Kun-Chang Yu, Y Yan, P Mohindra, R Timmerman, A Sawant & E Vicente. (2021) Virtual bronchoscopy-guided lung SAbR: dosimetric implications of using AAA versus Acuros XB to calculate dose in airways. Biomedical Physics & Engineering Express 7:6, pages 065010.
Crossref
Crossref
Colton Baley, Neil Kirby, Timothy Wagner, Nikos Papanikolaou, Pamela Myers, Karl Rasmussen, Sotirios Stathakis & Daniel Saenz. (2021) On the evaluation of mobile target trajectory between four‐dimensional computer tomography and four‐dimensional cone‐beam computer tomography. Journal of Applied Clinical Medical Physics 22:7, pages 198-207.
Crossref
Crossref
Michiel A. Ijsseldijk, Melina Shoni, Charles Siegert, Bastiaan Wiering, Anton K.C. van Engelenburg, Thomas C. Tsai, Richard P.G. ten Broek & Abraham Lebenthal. (2021) Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis. Clinical Lung Cancer 22:3, pages e235-e292.
Crossref
Crossref
Roman O. Kowalchuk, Michael R. Waters, Sunil W. Dutta, Marie L. Mack, K. Martin Richardson, Kelly Spencer, Kara D. Romano, James M. Larner, Jason P. Sheehan & C. Ronald Kersh. (2021) Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes. Advances in Radiation Oncology 6:3, pages 100612.
Crossref
Crossref
Anna Wrona & Francoise Mornex. (2021) Hypofractionation in Early Stage Non-Small Cell Lung Cancer. Seminars in Radiation Oncology 31:2, pages 97-104.
Crossref
Crossref
Isabel Rodrigues, Tiago Figueiredo, João Gagean, Carolina Ferreira, André Laranja, Tiago Ramos, Sofia Conde, Diana Moreira & Joana Cardia. (2020) Prognostic factors and clinical outcomes after stereotactic radiotherapy for primary lung tumors. Reports of Practical Oncology & Radiotherapy 25:6, pages 943-950.
Crossref
Crossref
William R. Kennedy, Pamela P. Samson, Prashant Gabani, John Nikitas, Jeffrey D. Bradley, Michael C. Roach & Clifford G. Robinson. (2020) Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLC. Radiotherapy and Oncology 150, pages 206-210.
Crossref
Crossref
May N. Tsao, Lieke in ’t Ven, Patrick Cheung, Ian Poon, Yee Ung & Alexander V. Louie. (2020) Stereotactic Body Radiation Therapy for Extracranial Oligometastatic Non–small-cell Lung Cancer: A Systematic Review. Clinical Lung Cancer 21:2, pages 95-105.e1.
Crossref
Crossref
Can Li, Li Wang, Qian Wu, Jiani Zhao, Fengming Yi, Jianjun Xu, Yiping Wei & Wenxiong Zhang. (2020) A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer. Medicine 99:34, pages e21715.
Crossref
Crossref
William R. Kennedy, Prashant Gabani, John Nikitas, Clifford G. Robinson, Jeffrey D. Bradley & Michael C. Roach. (2020) Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT. Radiotherapy and Oncology 142, pages 230-235.
Crossref
Crossref
Lawek Berzenji & Paul E. Van Schil. (2019) Surgery or stereotactic body radiotherapy for early-stage lung cancer: two sides of the same coin?. European Respiratory Journal 53:6, pages 1900711.
Crossref
Crossref
Neil B. Newman, Alexander D. Sherry, Daniel W. Byrne & Evan C. Osmundson. (2019) Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer. Journal of Radiation Oncology 8:2, pages 239-248.
Crossref
Crossref
Michiel A. IJsseldijk, Melina Shoni, Charles Siegert, Bastiaan Wiering, K.C. Anton van Engelenburg, Abraham Lebenthal & Richard P.G. ten Broek. (2019) Survival After Stereotactic Body Radiation Therapy for Clinically Diagnosed or Biopsy-Proven Early-Stage NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology 14:4, pages 583-595.
Crossref
Crossref
Christopher Cao, Daniel Wang, Caroline Chung, David Tian, Andreas Rimner, James Huang & David R. Jones. (2019) A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 157:1, pages 362-373.e8.
Crossref
Crossref
Waqar Haque, Vivek Verma, Praveen Polamraju, Andrew Farach, E. Brian Butler & Bin S. Teh. (2018) Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer. Radiotherapy and Oncology 129:2, pages 264-269.
Crossref
Crossref
Stefan S. Jeppesen, Lars-Erik Matzen, Carsten Brink, Rasa Bliucukiene, Søren Kasch, Tine Schytte, Charlotte Kristiansen & Olfred Hansen. (2018) Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic body radiotherapy. Journal of Geriatric Oncology 9:6, pages 575-582.
Crossref
Crossref
Govind Raghavan, Narek Shaverdian, Shawna Chan, Fang-I. Chu & Percy Lee. (2018) Comparing Outcomes of Patients With Early-Stage Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status. Clinical Lung Cancer 19:5, pages e759-e766.
Crossref
Crossref
Chih-Yen Tu, Te-Chun Hsia, Hsin-Yuan Fang, Ji-An Liang, Su-Tso Yang, Chia-Chin Li & Chun-Ru Chien. (2017) A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients. Radiology and Oncology 52:2, pages 181-188.
Crossref
Crossref
Takuro Miyazaki, Takuya Yamazaki, Daisuke Nakamura, Shuntaro Sato, Naoya Yamasaki, Tomoshi Tsuchiya, Keitaro Matsumoto, Ryotaro Kamohara, Go Hatachi & Takeshi Nagayasu. (2017) Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis. Surgery Today 47:12, pages 1476-1483.
Crossref
Crossref
Alexander Chi, Haiquan Chen, Sijin Wen, Haijuan Yan & Zhongxing Liao. (2017) Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis. Radiotherapy and Oncology 123:3, pages 346-354.
Crossref
Crossref
Conrad B. Falkson, Emily T. Vella, Edward Yu, Medhat El-Mallah, Robert Mackenzie, Peter M. Ellis & Yee C. Ung. (2017) Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non–Small-cell Lung Cancer: A Systematic Review. Clinical Lung Cancer 18:2, pages 105-121.e5.
Crossref
Crossref
Gokoulakrichenane Loganadane, Florent Martinetti, Olaf Mercier, Samar Krhili, François-Georges Riet, Rodrigue Mbagui, Hanh To, Cécile Le Péchoux & Antonin Levy. (2016) Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse. Cancer Treatment Reviews 50, pages 240-246.
Crossref
Crossref
Jan Nyman, Andreas Hallqvist, Jo-Åsmund Lund, Odd-Terje Brustugun, Bengt Bergman, Per Bergström, Signe Friesland, Rolf Lewensohn, Erik Holmberg & Ingmar Lax. (2016) SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiotherapy and Oncology 121:1, pages 1-8.
Crossref
Crossref
Stefan S. Jeppesen, Niels-Chr. G. Hansen, Tine Schytte, Morten Nielsen & Olfred Hansen. (2016) Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer. Lung Cancer 100, pages 90-95.
Crossref
Crossref
Christina D. Williams, Joseph K. Salama, Drew Moghanaki, Tomer Z. Karas & Michael J. Kelley. (2016) Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer. Journal of Thoracic Oncology 11:10, pages 1672-1681.
Crossref
Crossref
Yoshiro Matsuo, Kenji Yoshida, Hideki Nishimura, Yasuo Ejima, Daisuke Miyawaki, Haruka Uezono, Takeaki Ishihara, Hiroshi Mayahara, Takumi Fukumoto, Yonson Ku, Masato Yamaguchi, Koji Sugimoto & Ryohei Sasaki. (2016) Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. Journal of Radiation Research 57:5, pages 512-523.
Crossref
Crossref
Kyungim Kim, Keun Sang Oh, Dal Yong Park, Jae Young Lee, Beom Suk Lee, In San Kim, Kwangmeyung Kim, Ick Chan Kwon, Yoon Kim Sang & Soon Hong Yuk. (2016) Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targeting. Journal of Controlled Release 228, pages 141-149.
Crossref
Crossref
Jiyong Zhang, Vincent W. Wu, Jiayang Lu, Danli Hong & Zhixiong Lin. (2015) Dosimetric Verification of Stereotactic Body Radiation Therapy for Lung Cancer Treatment Plans Using Flattening Filter-free Beams. Tumori Journal 101:6, pages 631-636.
Crossref
Crossref
Sarah Walters, Sara Benitez-Majano, Patrick Muller, Michel P Coleman, Claudia Allemani, John Butler, Mick Peake, Marianne Grønlie Guren, Bengt Glimelius, Stefan Bergström, Lars Påhlman & Bernard Rachet. (2015) Is England closing the international gap in cancer survival?. British Journal of Cancer 113:5, pages 848-860.
Crossref
Crossref
Gino Boily, Édith Filion, George Rakovich, Neil Kopek, Lise Tremblay, Benoit Samson, Stéphanie Goulet & Isabelle Roy. (2015) Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non–Small-Cell Lung Cancer: CEPO Review and Recommendations. Journal of Thoracic Oncology 10:6, pages 872-882.
Crossref
Crossref
Joanne N. Davis, Clinton MedberyIIIIII, Sanjeev Sharma, David Perry, John Pablo, David J. D’Ambrosio, Heidi McKellar, Frank C. Kimsey, Paul N. Chomiak & Anand Mahadevan. (2015) Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry. Journal of Radiation Oncology 4:1, pages 55-63.
Crossref
Crossref
Yu-Sang Yang, Randy P. Carney, Francesco Stellacci & Darrell J. Irvine. (2014) Enhancing Radiotherapy by Lipid Nanocapsule-Mediated Delivery of Amphiphilic Gold Nanoparticles to Intracellular Membranes. ACS Nano 8:9, pages 8992-9002.
Crossref
Crossref
Carole A. Ridge, Mikhail Silk, Elena N. Petre, Joseph P. Erinjeri, William Alago, Robert J. Downey, Constantinos T. Sofocleous, Raymond H. Thornton & Stephen B. Solomon. (2014) Radiofrequency Ablation of T1 Lung Carcinoma: Comparison of Outcomes for First Primary, Metachronous, and Synchronous Lung Tumors. Journal of Vascular and Interventional Radiology 25:7, pages 989-996.
Crossref
Crossref
Stefania Volpe, Gaia Piperno, Francesca Colombo, Annalisa Biffi, Stefania Comi, Anna Maria Camarda, Alessia Casbarra, Federica Cattani, Filippo De Marinis, Lorenzo Spaggiari, Matthias Guckenberger, Roberto Orecchia, Daniela Alterio & Barbara Alicja Jereczek-Fossa. (2022) Hypofractionated Proton Therapy for Non-Small Cell Lung Cancer: Ready for Prime Time? A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref